Galecto, Inc. financial data

Symbol
GLTO on Nasdaq
Industry
Pharmaceutical Preparations
Location
75 State Street, Suite 100, Boston, Massachusetts
State of incorporation
Delaware
Fiscal year end
December 31
Latest financial report
Q1 2024 - Apr 29, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 451 % -31.7%
Debt-to-equity 26.8 % +69.1%
Return On Equity -87.1 % -1.9%
Return On Assets -68.7 % +6.91%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 27.1 M shares +5.61%
Common Stock, Shares, Outstanding 27.1 M shares +5.61%
Entity Public Float 58.9 M USD
Weighted Average Number of Shares Outstanding, Basic 27.1 M shares +5.61%
Weighted Average Number of Shares Outstanding, Diluted 27.1 M shares +5.61%

Income Statement

Label TTM Value / Value Unit Change %
Research and Development Expense 15.9 M USD -65%
General and Administrative Expense 12.8 M USD +3.28%
Operating Income (Loss) -32.2 M USD +44.3%
Nonoperating Income (Expense) 1.32 M USD +1553%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -38.3 M USD +37.8%
Income Tax Expense (Benefit) 0 USD
Net Income (Loss) Attributable to Parent -30.8 M USD +46.5%
Earnings Per Share, Basic -1.13 USD/shares +50.2%
Earnings Per Share, Diluted -1.13 USD/shares +50.2%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 21.1 M USD -15.9%
Marketable Securities, Current 6.08 M USD -78.4%
Assets, Current 30.5 M USD -46.5%
Property, Plant and Equipment, Net 73 K USD -78.8%
Operating Lease, Right-of-Use Asset 152 K USD -78.4%
Other Assets, Noncurrent 1.71 M USD -31.3%
Assets 32.5 M USD -49.7%
Accounts Payable, Current 1.67 M USD -53.1%
Employee-related Liabilities, Current 1.17 M USD +4.01%
Accrued Liabilities, Current 2.65 M USD -74.8%
Liabilities, Current 4.32 M USD -69.3%
Operating Lease, Liability, Noncurrent 66 K USD -79.9%
Liabilities 4.32 M USD -69.8%
Accumulated Other Comprehensive Income (Loss), Net of Tax 326 K USD
Retained Earnings (Accumulated Deficit) -262 M USD -13.4%
Stockholders' Equity Attributable to Parent 28.2 M USD -44.1%
Liabilities and Equity 32.5 M USD -49.7%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -5.94 M USD +35%
Net Cash Provided by (Used in) Financing Activities 2.88 M USD +467%
Net Cash Provided by (Used in) Investing Activities 5.65 M USD +311%
Common Stock, Shares Authorized 300 M shares 0%
Common Stock, Shares, Issued 27.1 M shares +5.61%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 21.1 M USD -15.9%
Deferred Tax Assets, Valuation Allowance 63.4 M USD +18.6%
Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent 0.21 pure 0%
Deferred Tax Assets, Gross 63.4 M USD +18.6%
Operating Lease, Liability 155 K USD -77.4%
Depreciation 256 K USD +392%
Payments to Acquire Property, Plant, and Equipment 196 K USD -12.1%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -30.4 M USD +46.8%
Lessee, Operating Lease, Liability, to be Paid 161 K USD -78.1%
Property, Plant and Equipment, Gross 107 K USD -74.8%
Operating Lease, Liability, Current 155 K USD -65.7%
Lessee, Operating Lease, Liability, to be Paid, Year Two 17 K USD -94.2%
Lessee, Operating Lease, Liability, to be Paid, Year One 16 K USD -94.6%
Operating Lease, Weighted Average Discount Rate, Percent 0.08 pure 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 6 K USD -87.8%
Lessee, Operating Lease, Liability, to be Paid, Year Three 10 K USD -37.5%
Deferred Tax Assets, Operating Loss Carryforwards 52.4 M USD +19.8%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 10 M shares 0%
Operating Lease, Payments 509 K USD -8.62%
Additional Paid in Capital 289 M USD +2.92%
Preferred Stock, Shares Outstanding 0 shares
Deferred Tax Assets, Net of Valuation Allowance 15 K USD
Share-based Payment Arrangement, Expense 5.35 M USD -4.45%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%